Katsuya Yamada Selected Research

Phloretin

3/2021	Uptake of fluorescent D- and L-glucose analogues, 2-NBDG and 2-NBDLG, into human osteosarcoma U2OS cells in a phloretin-inhibitable manner.
7/2016	Erratum to: Uptake of a fluorescent L-glucose derivative 2-NBDLG into three-dimensionally accumulating insulinoma cells in a phloretin-sensitive manner.
1/2016	Uptake of a fluorescent L-glucose derivative 2-NBDLG into three-dimensionally accumulating insulinoma cells in a phloretin-sensitive manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katsuya Yamada Research Topics

Disease

4	Neoplasms (Cancer) 03/2021 - 01/2006
4	Hypoxia (Hypoxemia) 04/2007 - 06/2002
3	Insulinoma 03/2021 - 01/2016
3	Seizures (Absence Seizure) 06/2005 - 06/2002
2	Parkinson Disease (Parkinson's Disease) 01/2017 - 04/2009
1	Osteosarcoma (Osteogenic Sarcoma) 03/2021
1	Ascites 01/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Body Weight (Weight, Body) 11/2016
1	Parkinsonian Disorders (Parkinsonism) 11/2016
1	Cholangiocarcinoma 07/2016
1	Bile Duct Neoplasms (Bile Duct Cancer) 07/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2015
1	Ischemic Stroke 04/2015
1	Huntington Disease (Huntington's Disease) 04/2009
1	Decapitation 04/2007
1	Tachypnea 04/2007
1	Ischemia 04/2007
1	Liver Failure 01/2006
1	Acoustic Neuroma (Acoustic Neurinoma) 05/2005
1	Infarction (Infarctions) 09/2003
1	Reperfusion Injury 09/2003

Drug/Important Bio-Agent (IBA)

6	(L)-Isomer Glucose (L-Glucose)IBA 03/2021 - 01/2016
3	PhloretinIBA 03/2021 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 04/2020 - 04/2009
3	Adenosine Triphosphate (ATP)IBA 04/2007 - 06/2002
2	2- (N- (7- nitrobenz- 2- oxa- 1,3- diazol- 4- yl)amino)- 2- deoxyglucoseIBA 03/2021 - 04/2020
2	CarcinogensIBA 01/2018 - 07/2016
2	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 11/2016
2	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 04/2015
1	cyclopropaneIBA 01/2018
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 11/2016
1	Temozolomide (Temodar)FDA LinkGeneric 11/2016
1	Alkylating AgentsIBA 11/2016
1	Cholinergic Agents (Cholinergics)IBA 11/2016
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 11/2016
1	Dopamine Receptors (Dopamine Receptor)IBA 11/2016
1	Contrast MediaIBA 07/2016
1	nitrosobis(2-oxopropyl)amine (NBOP)IBA 07/2016
1	Poly (ADP-Ribose) Polymerase-1IBA 04/2015
1	NAD (NADH)IBA 04/2015
1	Neuroprotective AgentsIBA 04/2015
1	MP 124IBA 04/2015
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 04/2009
1	PotassiumIBA 04/2007
1	SodiumIBA 01/2006
1	KATP ChannelsIBA 06/2005
1	Proteins (Proteins, Gene)FDA Link 05/2005

Therapy/Procedure

1	Deep Brain Stimulation 11/2016
1	Ligation 07/2016
1	Anesthesia 04/2007
1	Therapeutics 01/2006
1	Stents 01/2006